Association between ticagrelor plasma concentration and bleeding events in Chinese patients with acute coronary syndrome-Reference-Cited by-同舟云学术

Association between ticagrelor plasma concentration and bleeding events in Chinese patients with acute coronary syndrome

Published:2022-06-19 Issue:11 Volume:88 Page:4870-4880
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Yang Jing¹²,Qi Guangzhao¹²,Hu Fudong³,Zhang Xiaojian¹²,Xing Yu³,Wang Peile¹²^ORCID

Affiliation:

1. Department of Pharmacy First Affiliated Hospital of Zhengzhou University Zhengzhou P. R. China

2. Henan Key Laboratory of Precision Clinical Pharmacy Zhengzhou University Zhengzhou P. R. China

3. Department of Cardiology First Affiliated Hospital of Zhengzhou University Zhengzhou P. R. China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15422

Reference38 articles.

1. Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy

2. Part 10: Acute Coronary Syndromes

3. European Resuscitation Council Guidelines for Resuscitation 2015 Section 8. Initial management of acute coronary syndromes

4. Guidelines for rapid diagnosis and treatment of acute coronary syndrome in emergency department (2019);Branch of emergency physicians of Chinese medical doctor association;Chin J Emerg Med,2019

5. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation;Clinical Pharmacokinetics;2024-01-20

2. Fluorescence quenching-based immunological probe for ticagrelor monitoring;Frontiers in Bioengineering and Biotechnology;2023-11-28

3. Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention;BMC Cardiovascular Disorders;2023-03-29